Jörg Mahlich - Publications, H-index & Citations

Jörg Mahlich

heinrich heine university duesseldorf

25H指数

162论文数

1.8K被引数

收录论文 34

发表时间

Willingness to Pay for Treatment Attributes in Diffuse Large B-Cell Lymphoma: A Discrete Choice Experiment in Japan 弥漫性大B细胞淋巴瘤治疗属性支付意愿：一项日本离散选择实验

Clinical Drug Investigation

IF2.7

2026-04-10

OAAI

Yasuyuki Arai; Timothy Bolt; Hikaru Onishi; Michael LoPresti; Victoria Arguissain; Jörg Mahlich

Risk attitudes and value of hope: survey results from Japanese hematologists and oncologists treating patients with diffuse large B-cell lymphoma 风险态度与希望价值：来自治疗弥漫性大B细胞淋巴瘤的日本血液学家和肿瘤学家的调查结果

Scientific Reports

IF3.9

2026-03-31

OAAI

Yasuyuki Arai; Timothy Bolt; Hikaru Onishi; Michael LoPresti; Victoria Arguissain; Jörg Mahlich

Systematic literature review to identify prognostic factors of efficacy and safety outcomes of chimeric antigen receptor T-Cell therapies in diffuse large B-Cell lymphoma 系统评价文献以识别嵌合抗原受体T细胞疗法在弥漫性大B细胞淋巴瘤中的疗效和安全性结局的预后因素

Journal of Cancer Research and Clinical Oncology

IF2.8

2025-07-07

OAAI

Julia K. Schleifenbaum; Jan-Michel Heger; Jonas Jost; Umberto Rosato; Sybille Riou; Peter Borchmann; Stefan Walzer; Jörg Mahlich

Identification of Adjustment Variables in Indirect Comparisons: A Rapid Review of CAR-T Therapies for Diffuse Large B-Cell Lymphoma 间接比较中调整变量的识别：弥漫性大B细胞淋巴瘤CAR-T疗法的一项快速综述

CANCERS

IF4.4

2025-04-15

OAAI

Riou, Sybille; Rungaldier, Stefanie; Mahlich, Joerg

Survival outcomes of patients with diffuse large B-cell lymphoma undergoing autologous stem cell transplantation in Germany: real-world evidence from an administrative database between 2010 and 2019

FRONTIERS IN ONCOLOGY

IF3.3

2024-10-09

OAAI

Heger, Jan-Michel; Borchmann, Peter; Riou, Sybille; Werner, Barbara; Papadimitrious, Michael S.; Mahlich, Joerg

The philosophy of pharmaceutical regulation-Paternalism or freedom of choice?

FRONTIERS IN MEDICINE

IF3

2023-10-27

OAAI

Mahlich, Joerg; Riou, Sybille; Verry, Matthieu

Unlocking the value of innovative medicines: Insights from the advanced therapy medicinal products (ATMP) innovation systems in Germany and Sweden 释放创新药物的价值: 来自德国和瑞典先进治疗药物 (ATMP) 创新系统的见解

health policy

IF3.7

2023-06-01

OAAI

Fischer, Piret; Reiss, Thomas; Mahlich, Jorg; Gicquel, Erwan; Aichinger, Heike; Pullmann, Liliya; Bratan, Tanja

Healthcare Resource Utilization and Associated Costs of German Patients with Diffuse Large B-Cell Lymphoma: A Retrospective Health Claims Data Analysis

ONCOLOGY AND THERAPY

IF3.2

2022-11-29

OAAI

Borchmann, Peter; Heger, Jan-Michel; Mahlich, Jorg; Papadimitrious, Michael S.; Riou, Sybille; Werner, Barbara

Health Resource Utilization and Associated Health Care Costs of Biologic Disease-Modifying Antirheumatic Drugs in German Patients With Psoriatic Arthritis

ARTHRITIS CARE & RESEARCH

IF3.3

2022-06-02

OAAI

Sewerin, Philipp; Borchert, Kathrin; Meise, Dominic; Schneider, Matthias; Mahlich, Joerg

Hospitalization rates and therapy costs of German schizophrenia patients who are initiated on long acting injectable medication

EUROPEAN NEUROPSYCHOPHARMACOLOGY

IF6.7

2019-12-01

PREAI

Wimmer, A.; Mahlich, J.; Olbrich, K.; Wolff-Menzler, C.

Modeling the Choice Between Risperidone Long-Acting Injectable and Generic Risperidone from the Perspective of a Japanese Hospital

NEUROLOGY AND THERAPY

IF4.8

2019-08-10

OAAI

Nakamura, Yusuke; Shibata, Isao; Mahlich, Joerg

Drug Survival of Biological Therapies for Psoriasis Treatment in Germany and Associated Costs: A Retrospective Claims Database Analysis

ADVANCES IN THERAPY

IF4

2019-05-17

PREAI

Mahlich, Joerg; Alba, Aranzazu; El Hadad, Laila; Leisten, Marie-Kristin; Peitsch, Wiebke K.

Hematologists' Preferences for First-line Therapy Characteristics for Multiple Myeloma in Japan: Attribute Rating and Discrete Choice Experiment

CLINICAL THERAPEUTICS

IF3.6

2018-02-01

OAAI

Bolt, Timothy; Mahlich, Joerg; Nakamura, Yusuke; Nakayama, Masahiko

Impact of patient characteristics and treatment procedures on hospitalization cost and length of stay in Japanese patients with influenza: A structural equation modelling approach

INFLUENZA AND OTHER RESPIRATORY VIRUSES

IF4.2

2017-10-27

OAAI

Sruamsiri, Rosarin; Ferchichi, Sameh; Jamotte, Aurelien; Toumi, Mondher; Kubo, Hiroshi; Mahlich, Jorg

The relationship between socio-demographic factors, health status, treatment type, and employment outcome in patients with inflammatory bowel disease in Japan

BMC PUBLIC HEALTH

IF3.6

2017-07-04

OAAI

Mahlich, J.; Matsuoka, K.; Nakamura, Y.; Sruamsiri, R.

THE UNDERRATED PREVALENCE OF DEPRESSION IN PATIENTS WITH RHEUMATOID ARTHRITIS

ANNALS OF THE RHEUMATIC DISEASES

IF20.6

2017-06-01

OAAI

Sruamsiri, R.; Kaneko, Y.; Mahlich, J.

Preferences Regarding Shared Decision-Making in Japanese Inflammatory Bowel Disease Patients 日本炎症性肠病患者的共同决策偏好

ADVANCES IN THERAPY

IF4

2016-11-02

OAAI

Morishige, Ryuji; Nakajima, Hiroshi; Yoshizawa, Kazutake; Mahlich, Joerg; Sruamsiri, Rosarin

PATIENT PREFERENCES VERSUS PHYSICIAN PERCEPTIONS OF TREATMENT DECISIONS IN ADVANCE STAGE PROSTATE CANCER

VALUE IN HEALTH

IF6

2016-11-01

OAAI

Yoshizawa, K.; Mahlich, J.; Nakayama, M.; Kobayashi, H.; Takahashi, Y.; Saito, K.; Tsubota, A.; Uemura, H.; Masayuki, T.

TREATMENT RESISTANT DEPRESSION DEVELOPMENT FROM MAJOR DEPRESSIVE DISORDER: A CLAIMS DATABASE ANALYSIS IN JAPAN

VALUE IN HEALTH

IF6

2016-11-01

OAAI

Tsukazawa, S. K.; Fife, D.; Shimamoto, K.; Mahlich, J.

Simeprevir with pegylated interferon alfa 2a plus ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a meta-analysis and historical comparison

BMC INFECTIOUS DISEASES

IF3

2016-01-11

OAAI

Andersohn, Frank; Claes, Anne-Kathrin; Kulp, Werner; Mahlich, Joerg; Rockstroh, Juergen Kurt

研究方向